	pka value	8.400992831782785
	low pka	8.387525504419788
	predecessor	5.478018092611209
	omeprazole	4.245655916361931
	research effort	4.114613162183185
¡°	Protonix	3.5395240680930398
¡°	ppi	3.180261625152409
	PPI molecular backbone	2.7522512932943966
	pyridine ring	2.5825196496825167
	first commercialize PPI compound	2.171903801457652
	Prilosec	2.1254903706195405
	Entegris	2.1254903706195405
	methoxy group	1.9122645409077865
	compound pantoprazole	1.7162621100019704
	Wyeth	1.634035409053517
	cell secretory canaliculus	1.582502088160254
	Omeprazole	1.4175865476189426
	proton pump inhibitor	1.0281005235290184
	pump transport proton	0.7829366807735795
	stomach parietal cell	0.7769383649333597
	radical R2	0.7645148215314356
	radical consisting	0.7645148215314356
	antiulcer drug	0.7206617516839928
	employee layoff	0.7117682475858962
	Bryson article	0.7112026321754902
	HCI	0.7090900884480377
	Byk Gulden	0.7090900884480377
	Pantoprazole	0.7090900884480377
	CnH2n+i	0.7090900884480377
	-CH3	0.7090900884480377
	debt	0.7090900884480377
	SUCCESS	0.7090900884480377
	irreparable harm	0.69676680224381
	R4	0.5700128080507267
	gastric acid pump	0.5409408923775347
	logarithmic scale	0.5120389274835945
	gastric acid secretion	0.48807781232270714
	gastric acid disorder	0.45329916389233466
	KCI	0.4090219113662129
	r3	0.4090219113662129
	acid activate prodrug	0.3806606955234642
	benzimidazole ring	0.3733110243857937
	AB Hassle	0.3621101691852369
	potassium ion	0.35855397665594485
	GERD	0.35454504422401883
	MERITS	0.35454504422401883
	potassium chloride	0.343420761745143
	heartburn	0.2851257534547749
	R3	0.2851257534547749
	Ward	0.28192720072441474
	gastro esophageal reflux disease	0.27341693137529116
	methylsulfinyl bridge	0.2588574482374919
	methyl group	0.2526234344109012
	hydrochloric acid	0.25086099911725424
	extrusion	0.21607245854786125
	AstraZeneca	0.21607245854786125
	enzyme h	0.20536931671859268
	5-year term extension	0.1827199280321172
	irreversible price erosion	0.17958629955121438
	follow harm	0.17712343225331725
	alkyl group	0.154717999897551
	one cysteine amino acid	0.14487925348690328
	Amazon.com	0.14459414870660176
	blockbuster drug	0.1442529557050853
	pharmacology section	0.11454192466870305
	preliminary injunction stage	0.11447582742355719
	USPTO	0.0859091007777777
	vulnerability	0.0859091007777777
	well stability	0.08212186753459172
	pH	0.08039693647274646
	preliminary relief	0.07751629238565322
	highly acidic environment	0.0745001893169234
	exchange	0.07059892427727024
	oxygen	0.06748225626443799
	lead compound	0.06632390262705594
	Appellants	0.06577285395428933
	profit	0.06577285395428933
	designation	0.060271869751196826
	inability	0.0599771473475483
	carbon hydrogen atom	0.05147845647040326
	four prior art compound	0.04947504135054083
	Andrx Pharms	0.04882442869684004
	hardship	0.048238410821662435
	substantial loss	0.04368853678392311
	opposition	0.04358411790440411
	Hatch Waxman Act	0.042740519668873836
	exclusive licensee	0.034754582792216805
	injunction favorable impact	0.03214759848247352
	availability	0.030135934875598413
	successful commercialization	0.027787818738537817
	New Jersey	0.02681941360423659
	conjunction	0.025514519821425167
	reversal	0.023736955749043078
	concur opinion	0.0231666796806941
	decrease	0.023139621667943346
	substitution	0.021767692792840385
	licensee motion	0.020347973072354225
	Barnesandnoble.com Inc.	0.019992382449182767
	research opportunity	0.01950335228191742
	active ingredient	0.01849137061656258
	paragraph IV certification	0.018387200961074598
	appellee	0.017426137218158316
	Genentech	0.017426137218158316
	either likelihood	0.015028536795790581
	respective ANDA application	0.013746675099276726
	FDA approval	0.01331722178966727
	Opinion Opinion	0.012595719058222866
	similarly direct ANDA application	0.012390802277439723
	account	0.011238870844128503
	request relief	0.010309849913206723
	testing	0.010185991523738096
	modification	0.01004772555045398
	motivation	0.010024283095597462
	i. BACKGROUND	0.00919411200236283
	market share	0.008941495377287861
	many drug company	0.008626995834123243
	prima facie	0.008531447220404503
	inner portion	0.00852623466786424
	generic version	0.008377139025066751
	active form	0.008364869744544002
	trade name	0.00815819268065598
	introduction	0.008113275307483868
	objective indicia	0.007817132357753226
	patient body	0.0077011430868098845
	reasonable likelihood	0.007515902903945216
	general formula	0.006961742856460562
	Abbreviated New Drug Application	0.0064099511844677316
	U.S. Food Drug Administration	0.005481184861085849
	three main structural element	0.005183291319626243
	heavy burden	0.004880274393584219
	infringer obviousness defense	0.004805567812721921
	sound discretion	0.004423186668289469
	desirable characteristic	0.0042349073626356684
	June	0.003869647017991996
	substantial merit	0.0037242760168528398
	et al	0.003632341483688381
	alleged infringer	0.002849061840048755
	structural difference	0.002831442821645819
	February	0.0025137384856877706
	accuse infringer	0.002452961250360803
	July	0.0019364426089225756
	discussion	0.0019364426089225756
	four factor	0.0015150315530035171
	defendant interpretation	0.0013980112823968804
	defendant position	0.0013669847751697699
	holder	0.0013458155715351512
	ultimate burden	0.0012742267958725595
	balance	0.0011900585358548715
	defendant obviousness analysis	0.001089677213808718
	substantial question	0.0009327039879803346
	April	0.0009218966691918118
	actual invalidity	0.0008269105934595454
	January	0.0007565130208158496
	owner	0.0007526986312190432
	March	0.0007200146285262667
	showing	0.0007197132410365665
	less proof	0.0006884687602536378
	first two factor	0.0006793271691137556
	public interest	0.0006583659781834429
	effective filing date	0.0006130973294990359
	court discretion	0.0006040962977743397
	erroneous finding	0.0005065285453325171
	II	0.00046051820995893976
	district court examination	0.00031847027523981944
	common example	0.00015951526504317121
	skill	0.0001168547263450453
	right structure	0.00010730061025797913
	background	6.8036373506942e-05
	district court failure	5.093561356922226e-05
	U.S. Patent Trademark Office	4.359574511253501e-05
	holding	3.4968271564966276e-05
	jurisdiction	2.885436287784441e-05
	follow allege error	1.9824230061966377e-05
	suit	1.4578449512563031e-05
	trial	1.0103820489848169e-05
	decision	6.543595037053742e-06
	part	6.0561796840694755e-06
	light	2.3351151607686365e-06
	district court determination	1.7061263859140326e-06
	district court order	1.1321386780775419e-06
	follow prior art reference	9.161891681626349e-07
	Idaho	7.382264749858904e-07
	action	4.124810882852327e-07
	issue	3.952317927261625e-09
	District	0.0
	Court	0.0
	Appeals	0.0
	United States	0.0
